Specialty OB/GYN
-
Featured
Developing Precision Therapies for Ovarian Cancer
Researchers are working to develop next-generation tailored treatment protocols for ovarian cancer utilizing precision medicine techniques.
-
Featured
Risk of Renal Failure After Cardiopulmonary Bypass Depends on Preop Renal Function and Pump Time
In terms of the potential for acute renal failure, prolonged time on cardiopulmonary bypass is riskiest for patients with marked renal impairment preoperatively, Massachusetts General Hospital cardiac surgeons have observed. Here they provide guidance for real-time decision-making in the operating room.
-
Featured
Outpatient Expectant Management of Term PROM Has Mixed Results
Outpatient expectant management of prelabor rupture of membranes (PROM) at term is associated with longer intervals between PROM and delivery, but shorter intervals between admission and delivery.
-
Vaginal Microbiome May Not Differ Between Black, White Postmenopausal Women
Lactobacillus species, which appear to protect against HIV infection and cervical cancer, are similarly abundant in vaginal samples from Black and whitepostmenopausal women, according to a molecular study by Caroline M. Mitchell, MD, MPH, and colleagues.
OB/GYN contributors
-
Amanda Ramos, MD
Fellow, Gynecologic Oncology
Recent Article
Combination Immunotherapy May Be the Best Treatment for Certain Uterine Cancers
-
Andrea Edlow, MD, MSc
Maternal-Fetal Medicine Specialist , Investigator, Vincent Center for Reproductive Biology
Recent Article
Vertical Transmission of SARS-CoV-2 Is Rare but Immunity Is Compromised in Neonates
-
Ilona T. Goldfarb, MD
Maternal Fetal Medicine Specialist
Recent Article
Outpatient Tracking and Telehealth for Pregnant Women with Symptomatic COVID-19
-
Irene C. Souter, MD
Director, Preimplantation Genetic Diagnostics Program, Physician, Fertility Center
Recent Article
Exposure to Nitrogen Dioxide Increases Risk of Pregnancy Loss -
Jeffrey L. Ecker, MD
Chief, Department of Obstetrics & Gynecology
Recent Article
Mass General Department of OB/GYN Develops and Executes Three-Pronged Diversity Strategy
-
John Petrozza, MD
Chief, Division of Reproductive Medicine and IVF, Director, Massachusetts General Fertility Center, Co-director, Integrated Fibroid Program
Recent Article
Fertility Treatment Innovations Address Care Amid COVID-19 -
Marcela G. del Carmen, MD
Chief Medical Officer, Massachusetts General Physicians Organization, Gynecologic Oncologist, Center for Gynecologic Oncology
Recent Article
How Research Has Impacted Care for Cervical Cancer video
-
Marie Henderson, CNM, MSN
Nurse-Midwife
Recent Article
New Departmental Protocol Substantially Reduces Post-Cesarean Opioid Prescribing
-
Mary E. Sabatini, MD, PhD
Medical Director, Clinic for Reproductive Health and Cancer, Medical Director, Third Party Reproduction
Recent Article
The Müllerian Inhibiting Substance: Changing the Fertility Landscape for Young Women with Cancer
-
May M. Wakamatsu, MD
Director, Female Pelvic Medicine & Reconstructive Surgery, Vice Chair, Gynecology
Recent Article
IMPACT: A Standardized Tool for Assessment of Pelvic Floor Disorders
-
Milena M. Weinstein, MD
Director of Research, Female Pelvic Medicine and Reconstructive Surgery Fellowship, Co-director, Center for Pelvic Floor Disorders
Recent Article
IMPACT: A Standardized Tool for Assessment of Pelvic Floor Disorders
-
Sarah N. Bernstein, MD
Maternal Fetal Medicine Specialist, Medical director, Outpatient Obstetrics Program
Recent Article
Managing the Cardiovascular Complications of Substance Use Disorders During Pregnancy
-
Whitfield B. Growdon, MD
Center for Gynecologic Oncology
Recent Article
Understanding the Molecular Underpinnings of Gynecologic Cancers
-
William H. Barth, MD
Vice Chair, Obstetrics
Recent Article
Percutaneous Valve Replacement Therapy Sometimes an Option During Pregnancy
Obstetrics & Gynecology Care at Mass General
The Mass General Department of Obstetrics & Gynecology offers the highest level of care to women. Our clinical and research team is a leader in advancing treatments for gynecologic cancers, menopause, high-risk obstetrics, infertility and urogynecology.
